BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang Y, Li L, Liu C, Hong S, Zhang M. Peroxiredoxin 3 is resistant to oxidation-induced apoptosis of Hep-3b cells. Clin Transl Oncol 2014;16:561-6. [DOI: 10.1007/s12094-013-1117-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 Bigaud E, Corrales FJ. Methylthioadenosine (MTA) Regulates Liver Cells Proteome and Methylproteome: Implications in Liver Biology and Disease. Mol Cell Proteomics 2016;15:1498-510. [PMID: 26819315 DOI: 10.1074/mcp.M115.055772] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
2 Zhang N, Wang L, Duan Q, Lin L, Ahmed M, Wang T, Yao X. Metallothionein-I/II Knockout Mice Aggravate Mitochondrial Superoxide Production and Peroxiredoxin 3 Expression in Thyroid after Excessive Iodide Exposure. Oxid Med Cell Longev 2015;2015:267027. [PMID: 26101557 DOI: 10.1155/2015/267027] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
3 Koudelkova P, Costina V, Weber G, Dooley S, Findeisen P, Winter P, Agarwal R, Schlangen K, Mikulits W. Transforming Growth Factor-β Drives the Transendothelial Migration of Hepatocellular Carcinoma Cells. Int J Mol Sci 2017;18:E2119. [PMID: 28994702 DOI: 10.3390/ijms18102119] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
4 Hampton MB, Vick KA, Skoko JJ, Neumann CA. Peroxiredoxin Involvement in the Initiation and Progression of Human Cancer. Antioxid Redox Signal 2018;28:591-608. [PMID: 29237274 DOI: 10.1089/ars.2017.7422] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 8.3] [Reference Citation Analysis]
5 Marengo B, Nitti M, Furfaro AL, Colla R, Ciucis CD, Marinari UM, Pronzato MA, Traverso N, Domenicotti C. Redox Homeostasis and Cellular Antioxidant Systems: Crucial Players in Cancer Growth and Therapy. Oxid Med Cell Longev 2016;2016:6235641. [PMID: 27418953 DOI: 10.1155/2016/6235641] [Cited by in Crossref: 121] [Cited by in F6Publishing: 115] [Article Influence: 20.2] [Reference Citation Analysis]
6 Park MH, Jo M, Kim YR, Lee CK, Hong JT. Roles of peroxiredoxins in cancer, neurodegenerative diseases and inflammatory diseases. Pharmacol Ther 2016;163:1-23. [PMID: 27130805 DOI: 10.1016/j.pharmthera.2016.03.018] [Cited by in Crossref: 73] [Cited by in F6Publishing: 74] [Article Influence: 12.2] [Reference Citation Analysis]
7 Sharapov MG, Novoselov VI. Catalytic and Signaling Role of Peroxiredoxins in Carcinogenesis. Biochemistry (Mosc) 2019;84:79-100. [PMID: 31216969 DOI: 10.1134/S0006297919020019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
8 Myers CR. Enhanced targeting of mitochondrial peroxide defense by the combined use of thiosemicarbazones and inhibitors of thioredoxin reductase. Free Radical Biology and Medicine 2016;91:81-92. [DOI: 10.1016/j.freeradbiomed.2015.12.008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
9 Xing X, Liang D, Huang Y, Zeng Y, Han X, Liu X, Liu J. The application of proteomics in different aspects of hepatocellular carcinoma research. Journal of Proteomics 2016;145:70-80. [DOI: 10.1016/j.jprot.2016.03.050] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
10 Ow SH, Chua PJ, Bay BH. Epigenetic regulation of peroxiredoxins: Implications in the pathogenesis of cancer. Exp Biol Med (Maywood) 2017;242:140-7. [PMID: 27633575 DOI: 10.1177/1535370216669834] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
11 Satari M, Aghadavod E, Mobini M, Asemi Z. Association between miRNAs expression and signaling pathways of oxidative stress in diabetic retinopathy. J Cell Physiol 2019;234:8522-32. [PMID: 30478922 DOI: 10.1002/jcp.27801] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
12 Ramasamy P, Larkin AM, Linge A, Tiernan D, McAree F, Horgan N, Moriarty P, Beatty S, Murphy CC, Clynes M, Kennedy S, Meleady P. PRDX3 is associated with metastasis and poor survival in uveal melanoma. J Clin Pathol 2020;73:408-12. [PMID: 31771972 DOI: 10.1136/jclinpath-2019-206173] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
13 Carrella S, Massa F, Indrieri A. The Role of MicroRNAs in Mitochondria-Mediated Eye Diseases. Front Cell Dev Biol 2021;9:653522. [PMID: 34222230 DOI: 10.3389/fcell.2021.653522] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Godahewa G, Kim Y, Dananjaya S, Jayasooriya R, Noh JK, Lee J, De Zoysa M. Mitochondrial peroxiredoxin 3 (Prx3) from rock bream (Oplegnathus fasciatus): Immune responses and role of recombinant Prx3 in protecting cells from hydrogen peroxide induced oxidative stress. Fish & Shellfish Immunology 2015;43:131-41. [DOI: 10.1016/j.fsi.2014.12.011] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
15 Xu X, Lu D, Zhuang R, Wei X, Xie H, Wang C, Zhu Y, Wang J, Zhong C, Zhang X, Wei Q, He Z, Zhou L, Zheng S. The phospholipase A2 activity of peroxiredoxin 6 promotes cancer cell death induced by tumor necrosis factor alpha in hepatocellular carcinoma. Mol Carcinog. 2016;55:1299-1308. [PMID: 26293541 DOI: 10.1002/mc.22371] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
16 Li L, Yu A. The functional role of peroxiredoxin 3 in reactive oxygen species, apoptosis, and chemoresistance of cancer cells. J Cancer Res Clin Oncol 2015;141:2071-7. [DOI: 10.1007/s00432-015-1916-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]